Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells

Antibody production is the main effector function of B cells. Rawlings and colleagues show that Trypanosome cruzi induces rapid IL-17 production by B cells that is required for parasite control. Here we identified B cells as a major source of rapid, innate-like production of interleukin 17 (IL-17) i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature immunology 2013-05, Vol.14 (5), p.514-522
Hauptverfasser: Bermejo, Daniela A, Jackson, Shaun W, Gorosito-Serran, Melisa, Acosta-Rodriguez, Eva V, Amezcua-Vesely, Maria C, Sather, Blythe D, Singh, Akhilesh K, Khim, Socheath, Mucci, Juan, Liggitt, Denny, Campetella, Oscar, Oukka, Mohamed, Gruppi, Adriana, Rawlings, David J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antibody production is the main effector function of B cells. Rawlings and colleagues show that Trypanosome cruzi induces rapid IL-17 production by B cells that is required for parasite control. Here we identified B cells as a major source of rapid, innate-like production of interleukin 17 (IL-17) in vivo in response to infection with Trypanosoma cruzi . IL-17 + B cells had a plasmablast phenotype, outnumbered cells of the T H 17 subset of helper T cells and were required for an optimal response to this pathogen. With both mouse and human primary B cells, we found that exposure to parasite-derived trans-sialidase in vitro was sufficient to trigger modification of the cell-surface mucin CD45, which led to signaling dependent on the kinase Btk and production of IL-17A or IL-17F via a transcriptional program independent of the transcription factors RORγt and Ahr. Our combined data suggest that the generation of IL-17 + B cells may be a previously unappreciated feature of innate immune responses required for pathogen control or IL-17-mediated autoimmunity.
ISSN:1529-2908
1529-2916
DOI:10.1038/ni.2569